Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: Rituximab in combination with gemcitabine plus cisplatin in patients with recurrent and metastatic head and neck squamous cell carcinoma: a phase I trial

Fig. 2

Computed tomography (CT) images of one responder. The patient had primary tongue cancer that was refractory to chemoradiotherapy using triweekly cisplatin 100 mg/m2. a Baseline CT at the sagittal plane (b) After 2 months, CT at the sagittal plane revealed a tumor shrinkage. Evaluation at axial planes by RECIST criteria revealed a partial response

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us